NFSG
ODT

Newbridge Financial Services Group’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Newbridge Financial Services Group’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-47
Closed – – 1587
2022
Q1 		$0 Hold
47
– – ﹤0.01% 1611
2021
Q4 		$0 Hold
47
– – ﹤0.01% 1582
2021
Q3 		$1K Hold
47
– – ﹤0.01% 1363
2021
Q2 		$0 Hold
47
– – ﹤0.01% 1542
2021
Q1 		$1K Buy
+47
New +$888 ﹤0.01% 1363

Newbridge Financial Services Group's ODT Position: Q2 2022 in Review

Newbridge Financial Services Group sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q2 2022, closing a stake of 47 shares.

Newbridge Financial Services Group first reported a position in ODT in Q1 2021 and held it in 5 quarters. The position peaked at $1K in Q3 2021. 0 funds tracked by Wall St. Rank hold ODT as of Q2 2022.

  • Newbridge Financial Services Group reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Newbridge Financial Services Group sold 47 Odonate Therapeutics, Inc. Common Stock shares in Q2 2022.
  • Newbridge Financial Services Group first reported a position in Odonate Therapeutics, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
  • Newbridge Financial Services Group's Odonate Therapeutics, Inc. Common Stock position peaked at $1K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Newbridge Financial Services Group's 13F filing for Q2 2022, filed 15 Jul 2022.